Expert assessment of the attributes of high-cost medications: a case study of CAR T-cell therapy in the gulf cooperation council.

AlRuthia Y, Al Dallal S, Hamad A, Al Khalifa ME, Al-Sabahi S, Wani S, Alibrahim A, Alharbi I, Alhenaidi A, Almari M, Aloumi A, Aljalahma M

Open source

DOI: 10.3389/fphar.2026.1812612
Published: 2026
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1812612,
  title = {Expert assessment of the attributes of high-cost medications: a case study of CAR T-cell therapy in the gulf cooperation council.},
  author = {AlRuthia Y and Al Dallal S and Hamad A and Al Khalifa ME and Al-Sabahi S and Wani S and Alibrahim A and Alharbi I and Alhenaidi A and Almari M and Aloumi A and Aljalahma M},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1812612},
  url = {https://doi.org/10.3389/fphar.2026.1812612}
}

RIS

TY  - JOUR
TI  - Expert assessment of the attributes of high-cost medications: a case study of CAR T-cell therapy in the gulf cooperation council.
AU  - AlRuthia Y
AU  - Al Dallal S
AU  - Hamad A
AU  - Al Khalifa ME
AU  - Al-Sabahi S
AU  - Wani S
AU  - Alibrahim A
AU  - Alharbi I
AU  - Alhenaidi A
AU  - Almari M
AU  - Aloumi A
AU  - Aljalahma M
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1812612
UR  - https://doi.org/10.3389/fphar.2026.1812612
ER  -

APA

Y, A., S, A. D., A, H., ME, A. K., S, A., S, W., A, A., I, A., A, A., M, A., A, A., & M, A. (2026). Expert assessment of the attributes of high-cost medications: a case study of CAR T-cell therapy in the gulf cooperation council.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1812612

Source records

pubmed · retrieved 2026-11-10T10:23:05.874Z